GLI1 and diabetes mellitus: Moreover, we assessed the potential interaction effects between blood glucose (MBG, MAG, and GLI) and hepatorenal function (INR and eGFR) on POD (Table 5), to explore the possible metabolic pathway in which blood glucose influences POD risk in patients with DM who received CABG.